Evidence map›Paper›PMID 41210427›Full record

ArticleAME case reports2025

Isolated pulmonary metastasis occurring 10 years after total thyroidectomy and lymphadenectomy of a papillary thyroid carcinoma: a rare case report.

Xin Kang, Jing He, Jia-Min Liu

Abstract readCase Reports
In one paragraph

Article in AME case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xin KangDepartment of Pathology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
Jing HeDepartment of Pathology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.
Jia-Min LiuDepartment of Pathology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Papillary thyroid carcinoma (PTC) is the most common types of thyroid cancer; and the 10-year survival rate vary from 85% to 100%. Although the prognosis of PTC is generally favorable, recurrence and metastasis occur in approximately 4.3% to 35% of cases. Lymph node metastasis is relatively prevalent, while distant metastasis is comparatively infrequent. Case Description: This case report details a 61-year-old female diagnosed with PTC. The patient's pathological stage was pT3aN1aM0, and according to the American Thyroid Association (ATA) risk classification, she was categorized as intermediate risk. The patient underwent total thyroidectomy and local lymph node dissection; however, radioactive iodine-131 treatment was not administered. Postoperatively, the patient regularly consumed levothyroxine sodium yet failed to have her thyroid hormone levels monitored. A decade following the surgical procedure, the patient presented with isolated lung metastasis. However, given the lengthy history of the patient's thyroid cancer, the clinical diagnosis initially entertained the possibility of a primary lung tumor. Subsequently, a wedge resection of the lung was performed on the patient, and the postoperative pathology confirmed metastasis of PTC. Conclusions: This rare case appears to indicate that patients with intermediate-risk PTC, as defined by the ATA, may benefit from postoperative radioactive iodine-131 treatment. Such treatment could potentially minimize the likelihood of tumor recurrence and metastasis to the greatest possible extent.

Indexed as

case reportdifferential diagnosisisolated pulmonary metastasisPapillary thyroid carcinoma (PTC)recurrence

Identifiers

PMID41210427
PMCPMC12593051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.